IPXE:LSE:LSE-First Trust IPOX® Europe Equity Opportunities UCITS ETF USD (USD)

ETF | Others |

Last Closing

USD 21.9925

Change

-0.07 (-0.29)%

Market Cap

N/A

Volume

1.16K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-2.71 (-0.98%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-2.75 (-1.38%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+2.50 (+1.84%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.04 (+0.28%)

USD 584.80B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.04 (+0.25%)

USD 583.82B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.35 (-0.54%)

USD 266.08B
0QZO:LSE 0QZO

-0.75 (-0.78%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.12 (+0.41%)

USD 204.07B
0QZ3:LSE Qualcomm Inc.

-0.31 (-0.19%)

USD 202.26B

ETFs Containing IPXE:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.02% 81% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.02% 81% B- 76% C+
Trailing 12 Months  
Capital Gain 29.50% 85% B 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.50% 85% B 78% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.07% 61% D- 65% D
Dividend Return 9.07% 60% D- 65% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.15% 62% D 77% C+
Risk Adjusted Return 81.32% 82% B 89% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike